Miltenyi Biotec, Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Stem Cell Implantation in Patients Undergoing CABG
Phase 1
Terminated
- Conditions
- Ischemic CardiomyopathyCoronary Artery Disease
- First Posted Date
- 2012-11-06
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- Miltenyi Biotec, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT01721902
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
News
No news found